Cite
The methyltransferases METTL7A and METTL7B confer resistance to thiol-based histone deacetylase inhibitors
MLA
Robert W. Robey, et al. The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors. Oct. 2022. EBSCOhost, https://doi.org/10.1101/2022.10.07.511310.
APA
Robert W. Robey, Christina M. Fitzsimmons, Wilfried M. Guiblet, William J.E. Frye, José M. González Dalmasy, Li Wang, Drake A. Russell, Lyn M. Huff, Andrew J. Perciaccante, Fatima Ali-Rahmani, Crystal C. Lipsey, Heidi M. Wade, Allison V. Mitchell, Siddhardha S. Maligireddy, David Terrero, Donna Butcher, Elijah F. Edmondson, Lisa M. Jenkins, Tatiana Nikitina, … Pedro J. Batista. (2022). The methyltransferases METTL7A and METTL7B confer resistance to thiol-based histone deacetylase inhibitors. https://doi.org/10.1101/2022.10.07.511310
Chicago
Robert W. Robey, Christina M. Fitzsimmons, Wilfried M. Guiblet, William J.E. Frye, José M. González Dalmasy, Li Wang, Drake A. Russell, et al. 2022. “The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors,” October. doi:10.1101/2022.10.07.511310.